Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Survival after Kidney Transplantation during Childhood and Adolescence.

Francis A, Johnson DW, Melk A, Foster BJ, Blazek K, Craig JC, Wong G.

Clin J Am Soc Nephrol. 2020 Feb 19. pii: CJN.07070619. doi: 10.2215/CJN.07070619. [Epub ahead of print]

PMID:
32075809
2.

Sex and age as determinants for high blood pressure in pediatric renal transplant recipients: a longitudinal analysis of the CERTAIN Registry.

Sugianto RI, Schmidt BMW, Memaran N, Duzova A, Topaloglu R, Seeman T, König S, Dello Strologo L, Murer L, Özçakar ZB, Bald M, Shenoy M, Buescher A, Hoyer PF, Pohl M, Billing H, Oh J, Staude H, Pohl M, Genc G, Klaus G, Alparslan C, Grenda R, Rubik J, Krupka K, Tönshoff B, Wühl E, Melk A.

Pediatr Nephrol. 2020 Mar;35(3):415-426. doi: 10.1007/s00467-019-04395-4. Epub 2019 Dec 7.

PMID:
31811541
3.

Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease.

Holle J, Querfeld U, Kirchner M, Anninos A, Okun J, Thurn-Valsassina D, Bayazit A, Niemirska A, Canpolat N, Bulut IK, Duzova A, Anarat A, Shroff R, Bilginer Y, Caliskan S, Candan C, Harambat J, Özcakar ZB, Soylemezoglu O, Tschumi S, Habbig S, Yilmaz E, Balat A, Zurowska A, Cakar N, Kranz B, Ertan P, Melk A, Azukaitis K, Schaefer F.

Pediatr Nephrol. 2019 Dec;34(12):2571-2582. doi: 10.1007/s00467-019-04331-6. Epub 2019 Aug 19.

PMID:
31428929
4.

Binding to carboxypeptidase M mediates protective effects of fibrinopeptide Bβ15-42.

Sörensen-Zender I, Chen R, Rong S, David S, Melk A, Haller H, Schmitt R.

Transl Res. 2019 Nov;213:124-135. doi: 10.1016/j.trsl.2019.07.008. Epub 2019 Jul 26.

PMID:
31401267
5.

Determinants of Statural Growth in European Children With Chronic Kidney Disease: Findings From the Cardiovascular Comorbidity in Children With Chronic Kidney Disease (4C) Study.

Behnisch R, Kirchner M, Anarat A, Bacchetta J, Shroff R, Bilginer Y, Mir S, Caliskan S, Paripovic D, Harambat J, Mencarelli F, Büscher R, Arbeiter K, Soylemezoglu O, Zaloszyc A, Zurowska A, Melk A, Querfeld U, Schaefer F; and the 4C Study Consortium.

Front Pediatr. 2019 Jul 5;7:278. doi: 10.3389/fped.2019.00278. eCollection 2019.

6.

Computational Drug Screening Identifies Compounds Targeting Renal Age-associated Molecular Profiles.

Koppelstaetter C, Leierer J, Rudnicki M, Kerschbaum J, Kronbichler A, Melk A, Mayer G, Perco P.

Comput Struct Biotechnol J. 2019 Jun 25;17:843-853. doi: 10.1016/j.csbj.2019.06.019. eCollection 2019.

7.

Functionality and Cell Senescence of CD4/ CD8-Selected CD20 CAR T Cells Manufactured Using the Automated CliniMACS Prodigy® Platform.

Aleksandrova K, Leise J, Priesner C, Melk A, Kubaink F, Abken H, Hombach A, Aktas M, Essl M, Bürger I, Kaiser A, Rauser G, Jurk M, Goudeva L, Glienke W, Arseniev L, Esser R, Köhl U.

Transfus Med Hemother. 2019 Feb;46(1):47-54. doi: 10.1159/000495772. Epub 2019 Feb 4. Review.

8.

Isolated nocturnal and isolated daytime hypertension associate with altered cardiovascular morphology and function in children with chronic kidney disease: findings from the Cardiovascular Comorbidity in Children with Chronic Kidney Disease study.

Düzova A, Karabay Bayazit A, Canpolat N, Niemirska A, Kaplan Bulut I, Azukaitis K, Karagoz T, Oguz B, Erdem S, Anarat A, Ranchin B, Shroff R, Djukic M, Harambat J, Yilmaz A, Yildiz N, Ozcakar B, Büscher A, Lugani F, Wygoda S, Tschumi S, Zaloszyc A, Jankauskiene A, Laube G, Galiano M, Kirchner M, Querfeld U, Melk A, Schaefer F, Wühl E; 4C Study Consortium.

J Hypertens. 2019 Nov;37(11):2247-2255. doi: 10.1097/HJH.0000000000002160.

PMID:
31205198
9.

Effects of personalized endurance training on cellular age and vascular function in middle-aged sedentary women.

Eigendorf J, Melk A, Haufe S, Boethig D, Berliner D, Kerling A, Kueck M, Stenner H, Bara C, Stiesch M, Schippert C, Hilfiker A, Falk C, Bauersachs J, Thum T, Lichtinghagen R, Haverich A, Hilfiker-Kleiner D, Tegtbur U.

Eur J Prev Cardiol. 2019 Nov;26(17):1903-1906. doi: 10.1177/2047487319849505. Epub 2019 May 13. No abstract available.

PMID:
31084260
10.

Podocyte-Specific Sialylation-Deficient Mice Serve as a Model for Human FSGS.

Niculovic KM, Blume L, Wedekind H, Kats E, Albers I, Groos S, Abeln M, Schmitz J, Beuke E, Bräsen JH, Melk A, Schiffer M, Weinhold B, Münster-Kühnel AK.

J Am Soc Nephrol. 2019 Jun;30(6):1021-1035. doi: 10.1681/ASN.2018090951. Epub 2019 Apr 30.

PMID:
31040189
11.

Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children.

Azukaitis K, Ju W, Kirchner M, Nair V, Smith M, Fang Z, Thurn-Valsassina D, Bayazit A, Niemirska A, Canpolat N, Bulut IK, Yalcinkaya F, Paripovic D, Harambat J, Cakar N, Alpay H, Lugani F, Mencarelli F, Civilibal M, Erdogan H, Gellermann J, Vidal E, Tabel Y, Gimpel C, Ertan P, Yavascan O, Melk A, Querfeld U, Wühl E, Kretzler M, Schaefer F; 4C Study; ESCAPE Trial Group.

Kidney Int. 2019 Jul;96(1):214-221. doi: 10.1016/j.kint.2019.01.035. Epub 2019 Mar 20.

PMID:
31005273
12.

Greater Susceptibility for Metabolic Syndrome in Pediatric Solid Organ and Stem Cell Transplant Recipients.

Blöte R, Memaran N, Borchert-Mörlins B, Thurn-Valsassina D, Goldschmidt I, Beier R, Sauer M, Müller C, Sarganas G, Oh J, Büscher R, Kemper MJ, Sugianto RI, Epping J, Schmidt BMW, Melk A.

Transplantation. 2019 Nov;103(11):2423-2433. doi: 10.1097/TP.0000000000002675.

PMID:
30801541
13.

Time-dependent p53 inhibition determines senescence attenuation and long-term outcome after renal ischemia-reperfusion.

Baisantry A, Berkenkamp B, Rong S, Bhayadia R, Sörensen-Zender I, Schmitt R, Melk A.

Am J Physiol Renal Physiol. 2019 Jun 1;316(6):F1124-F1132. doi: 10.1152/ajprenal.00333.2018. Epub 2019 Feb 20.

PMID:
30785352
14.

Equally Interchangeable? How Sex and Gender Affect Transplantation.

Melk A, Babitsch B, Borchert-Mörlins B, Claas F, Dipchand AI, Eifert S, Eiz-Vesper B, Epping J, Falk CS, Foster B, Geyer S, Gjertson D, Greer M, Haubitz M, Lau A, Maecker-Kolhoff B, Memaran N, Messner HA, Ostendorf K, Samuel U, Schmidt BMW, Tullius SG, West L, Wong G, Zimmermann T, Berenguer M.

Transplantation. 2019 Jun;103(6):1094-1110. doi: 10.1097/TP.0000000000002655.

PMID:
30747857
15.

High Burden of Subclinical Cardiovascular Target Organ Damage After Pediatric Liver Transplantation.

Memaran N, Borchert-Mörlins B, Schmidt BMW, Sugianto RI, Wilke H, Blöte R, Baumann U, Bauer E, von Wick A, Junge N, Leiskau C, Pfister ED, Thurn-Valsassina D, Richter N, Goldschmidt I, Melk A.

Liver Transpl. 2019 May;25(5):752-762. doi: 10.1002/lt.25431. Epub 2019 Mar 25.

PMID:
30742355
16.

Urinary proteomics to diagnose chronic active antibody-mediated rejection in pediatric kidney transplantation - a pilot study.

Kanzelmeyer NK, Zürbig P, Mischak H, Metzger J, Fichtner A, Ruszai KH, Seemann T, Hansen M, Wygoda S, Krupka K, Tönshoff B, Melk A, Pape L.

Transpl Int. 2019 Jan;32(1):28-37. doi: 10.1111/tri.13363. Epub 2018 Nov 12.

17.

Impaired Microcirculation in Children After Kidney Transplantation: Everolimus Versus Mycophenolate Based Immunosuppression Regimen.

Ruben S, Kreuzer M, Büscher A, Büscher R, Thumfart J, Querfeld U, Staude H, Ahlenstiel-Grunow T, Melk A, Fischer DC, Leifheit-Nestler M, Pape L, Haffner D.

Kidney Blood Press Res. 2018;43(3):793-806. doi: 10.1159/000489915. Epub 2018 May 22.

18.

Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis.

Schaefer B, Bartosova M, Macher-Goeppinger S, Sallay P, Vörös P, Ranchin B, Vondrak K, Ariceta G, Zaloszyc A, Bayazit AK, Querfeld U, Cerkauskiene R, Testa S, Taylan C, VandeWalle J, Yap Y, Krmar RT, Büscher R, Mühlig AK, Drozdz D, Caliskan S, Lasitschka F, Fathallah-Shaykh S, Verrina E, Klaus G, Arbeiter K, Bhayadia R, Melk A, Romero P, Warady BA, Schaefer F, Ujszaszi A, Schmitt CP.

Kidney Int. 2018 Aug;94(2):419-429. doi: 10.1016/j.kint.2018.02.022.

PMID:
29776755
19.

Probing depth is an independent risk factor for HbA1c levels in diabetic patients under physical training: a cross-sectional pilot-study.

Wernicke K, Zeissler S, Mooren FC, Frech T, Hellmann S, Stiesch M, Grischke J, Linnenweber S, Schmidt B, Menne J, Melk A, Bauer P, Hillebrecht A, Eberhard J.

BMC Oral Health. 2018 Mar 16;18(1):46. doi: 10.1186/s12903-018-0491-9.

20.

Effects of nutritional vitamin D supplementation on markers of bone and mineral metabolism in children with chronic kidney disease.

Lerch C, Shroff R, Wan M, Rees L, Aitkenhead H, Kaplan Bulut I, Thurn D, Karabay Bayazit A, Niemirska A, Canpolat N, Duzova A, Azukaitis K, Yilmaz E, Yalcinkaya F, Harambat J, Kiyak A, Alpay H, Habbig S, Zaloszyc A, Soylemezoglu O, Candan C, Rosales A, Melk A, Querfeld U, Leifheit-Nestler M, Sander A, Schaefer F, Haffner D; 4C study consortium; ESPN CKD-MBD working group.

Nephrol Dial Transplant. 2018 Dec 1;33(12):2208-2217. doi: 10.1093/ndt/gfy012.

PMID:
29481636
21.

Cardiovascular risk factors and subclinical organ damage after hematopoietic stem cell transplantation in pediatric age.

Borchert-Mörlins B, Memaran N, Sauer M, Maecker-Kolhoff B, Sykora KW, Blöte R, Bauer E, Schmidt BMW, Melk A, Beier R.

Bone Marrow Transplant. 2018 Aug;53(8):983-992. doi: 10.1038/s41409-018-0104-x. Epub 2018 Feb 9.

PMID:
29426831
22.

Early Effects of Renal Replacement Therapy on Cardiovascular Comorbidity in Children With End-Stage Kidney Disease: Findings From the 4C-T Study.

Schmidt BMW, Sugianto RI, Thurn D, Azukaitis K, Bayazit AK, Canpolat N, Eroglu AG, Caliskan S, Doyon A, Duzova A, Karagoz T, Anarat A, Deveci M, Mir S, Ranchin B, Shroff R, Baskin E, Litwin M, Özcakar ZB, Büscher R, Soylemezoglu O, Dusek J, Kemper MJ, Matteucci MC, Habbig S, Laube G, Wühl E, Querfeld U, Sander A, Schaefer F, Melk A; 4C Study Consortium.

Transplantation. 2018 Mar;102(3):484-492. doi: 10.1097/TP.0000000000001948.

PMID:
28926375
23.

Factors associated with cardiovascular target organ damage in children after renal transplantation.

Borchert-Mörlins B, Thurn D, Schmidt BMW, Büscher AK, Oh J, Kier T, Bauer E, Baig S, Kanzelmeyer N, Kemper MJ, Büscher R, Melk A.

Pediatr Nephrol. 2017 Nov;32(11):2143-2154. doi: 10.1007/s00467-017-3771-8. Epub 2017 Aug 13.

PMID:
28804814
24.

Low renal but high extrarenal phenotype variability in Schimke immuno-osseous dysplasia.

Lipska-Ziętkiewicz BS, Gellermann J, Boyer O, Gribouval O, Ziętkiewicz S, Kari JA, Shalaby MA, Ozaltin F, Dusek J, Melk A, Bayazit AK, Massella L, Hyla-Klekot L, Habbig S, Godron A, Szczepańska M, Bieniaś B, Drożdż D, Odeh R, Jarmużek W, Zachwieja K, Trautmann A, Antignac C, Schaefer F; PodoNet Consortium.

PLoS One. 2017 Aug 10;12(8):e0180926. doi: 10.1371/journal.pone.0180926. eCollection 2017.

25.

Molecular mechanisms of renal aging.

Schmitt R, Melk A.

Kidney Int. 2017 Sep;92(3):569-579. doi: 10.1016/j.kint.2017.02.036. Epub 2017 Jul 18. Review.

PMID:
28729036
26.

Metabolic acidosis is common and associates with disease progression in children with chronic kidney disease.

Harambat J, Kunzmann K, Azukaitis K, Bayazit AK, Canpolat N, Doyon A, Duzova A, Niemirska A, Sözeri B, Thurn-Valsassina D, Anarat A, Bessenay L, Candan C, Peco-Antic A, Yilmaz A, Tschumi S, Testa S, Jankauskiene A, Erdogan H, Rosales A, Alpay H, Lugani F, Arbeiter K, Mencarelli F, Kiyak A, Dönmez O, Drozdz D, Melk A, Querfeld U, Schaefer F; 4C Study Consortium.

Kidney Int. 2017 Dec;92(6):1507-1514. doi: 10.1016/j.kint.2017.05.006. Epub 2017 Jul 18.

PMID:
28729033
27.

Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children.

Trautmann A, Schnaidt S, Lipska-Ziętkiewicz BS, Bodria M, Ozaltin F, Emma F, Anarat A, Melk A, Azocar M, Oh J, Saeed B, Gheisari A, Caliskan S, Gellermann J, Higuita LMS, Jankauskiene A, Drozdz D, Mir S, Balat A, Szczepanska M, Paripovic D, Zurowska A, Bogdanovic R, Yilmaz A, Ranchin B, Baskin E, Erdogan O, Remuzzi G, Firszt-Adamczyk A, Kuzma-Mroczkowska E, Litwin M, Murer L, Tkaczyk M, Jardim H, Wasilewska A, Printza N, Fidan K, Simkova E, Borzecka H, Staude H, Hees K, Schaefer F; PodoNet Consortium.

J Am Soc Nephrol. 2017 Oct;28(10):3055-3065. doi: 10.1681/ASN.2016101121. Epub 2017 May 31.

28.

Autophagy in kidney transplants of sirolimus treated recipients.

Bhayana S, Baisantry A, Kraemer TD, Wrede C, Hegermann J, Bräsen JH, Bockmeyer C, Ulrich Becker J, Ochs M, Gwinner W, Haller H, Melk A, Schmitt R.

J Nephropathol. 2017 Mar;6(2):90-96. doi: 10.15171/jnp.2017.15. Epub 2016 Oct 22.

29.

Antagonism of profibrotic microRNA-21 improves outcome of murine chronic renal allograft dysfunction.

Schauerte C, Hübner A, Rong S, Wang S, Shushakova N, Mengel M, Dettling A, Bang C, Scherf K, Koelling M, Melk A, Haller H, Thum T, Lorenzen JM.

Kidney Int. 2017 Sep;92(3):646-656. doi: 10.1016/j.kint.2017.02.012. Epub 2017 Apr 8.

PMID:
28396121
30.

Early and Late Factors Impacting Patient and Graft Outcome in Pediatric Liver Transplantation: Summary of an ESPGHAN Monothematic Conference.

McLin VA, Allen U, Boyer O, Bucuvalas J, Colledan M, Cuturi MC, d'Antiga L, Debray D, Dezsofi A, Goyet JV, Dhawan A, Durmaz O, Falk C, Feng S, Fischler B, Franchi-Abella S, Frauca E, Ganschow R, Gottschalk S, Hadzic N, Hierro L, Horslen S, Hubscher S, Karam V, Kelly D, Maecker-Kolhoff B, Mazariegos G, McKiernan P, Melk A, Nobili V, Ozgenç F, Reding R, Sciveres M, Sharif K, Socha P, Toso C, Vajro P, Verma A, Wildhaber BE, Baumann U.

J Pediatr Gastroenterol Nutr. 2017 Sep;65(3):e53-e59. doi: 10.1097/MPG.0000000000001564.

PMID:
28319600
31.

Cardiovascular Phenotypes in Children with CKD: The 4C Study.

Schaefer F, Doyon A, Azukaitis K, Bayazit A, Canpolat N, Duzova A, Niemirska A, Sözeri B, Thurn D, Anarat A, Ranchin B, Litwin M, Caliskan S, Candan C, Baskin E, Yilmaz E, Mir S, Kirchner M, Sander A, Haffner D, Melk A, Wühl E, Shroff R, Querfeld U; 4C Study Consortium.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):19-28. doi: 10.2215/CJN.01090216. Epub 2016 Nov 8.

32.

The impact of autophagy on the development of senescence in primary tubular epithelial cells.

Baisantry A, Bhayana S, Wrede C, Hegermann J, Haller H, Melk A, Schmitt R.

Cell Cycle. 2016 Nov;15(21):2973-2979. Epub 2016 Oct 7.

33.

Genetic, Environmental, and Disease-Associated Correlates of Vitamin D Status in Children with CKD.

Doyon A, Schmiedchen B, Sander A, Bayazit A, Duzova A, Canpolat N, Thurn D, Azukaitis K, Anarat A, Bacchetta J, Mir S, Shroff R, Yilmaz E, Candan C, Kemper M, Fischbach M, Cortina G, Klaus G, Wuttke M, Köttgen A, Melk A, Querfeld U, Schaefer F; 4C Study Consortium.

Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1145-53. doi: 10.2215/CJN.10210915. Epub 2016 Jun 16.

34.

Practice recommendations for the monitoring of renal function in pediatric non-renal organ transplant recipients.

Filler G, Melk A, Marks SD.

Pediatr Transplant. 2016 May;20(3):352-63. doi: 10.1111/petr.12685. Epub 2016 Feb 25.

PMID:
26917052
35.

The yin and yang of autophagy in acute kidney injury.

Melk A, Baisantry A, Schmitt R.

Autophagy. 2016;12(3):596-7. doi: 10.1080/15548627.2015.1135284.

36.

Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic Syndrome.

Büscher AK, Beck BB, Melk A, Hoefele J, Kranz B, Bamborschke D, Baig S, Lange-Sperandio B, Jungraithmayr T, Weber LT, Kemper MJ, Tönshoff B, Hoyer PF, Konrad M, Weber S; German Pediatric Nephrology Association (GPN).

Clin J Am Soc Nephrol. 2016 Feb 5;11(2):245-53. doi: 10.2215/CJN.07370715. Epub 2015 Dec 14.

37.

Cell aging and kidney repair.

Susnik N, Melk A, Schmitt R.

Cell Cycle. 2015;14(22):3521-2. doi: 10.1080/15384101.2015.1032636. No abstract available.

38.

Autophagy Induces Prosenescent Changes in Proximal Tubular S3 Segments.

Baisantry A, Bhayana S, Rong S, Ermeling E, Wrede C, Hegermann J, Pennekamp P, Sörensen-Zender I, Haller H, Melk A, Schmitt R.

J Am Soc Nephrol. 2016 Jun;27(6):1609-16. doi: 10.1681/ASN.2014111059. Epub 2015 Oct 20.

39.

T Cell CX3CR1 Mediates Excess Atherosclerotic Inflammation in Renal Impairment.

Dong L, Nordlohne J, Ge S, Hertel B, Melk A, Rong S, Haller H, von Vietinghoff S.

J Am Soc Nephrol. 2016 Jun;27(6):1753-64. doi: 10.1681/ASN.2015050540. Epub 2015 Oct 8.

40.

Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.

Wuttke M, Wong CS, Wühl E, Epting D, Luo L, Hoppmann A, Doyon A, Li Y; CKDGen Consortium, Sözeri B, Thurn D, Helmstädter M, Huber TB, Blydt-Hansen TD, Kramer-Zucker A, Mehls O, Melk A, Querfeld U, Furth SL, Warady BA, Schaefer F, Köttgen A.

Nephrol Dial Transplant. 2016 Feb;31(2):262-9. doi: 10.1093/ndt/gfv342. Epub 2015 Sep 28.

41.

Renal phenotype of young and old telomerase-deficient mice.

Schildhorn C, Jacobi C, Weissbrodt A, Hermstedt C, Westhoff JH, Hömme M, Bhayadia R, Gretz N, Falk CS, Schmitt R, Bröcker V, Kränzlin B, Melk A.

Mech Ageing Dev. 2015 Sep;150:65-73. doi: 10.1016/j.mad.2015.08.004. Epub 2015 Aug 12.

PMID:
26277387
42.

Molecular aspects of renal senescence.

Schmitt R, Susnik N, Melk A.

Curr Opin Organ Transplant. 2015 Aug;20(4):412-6. doi: 10.1097/MOT.0000000000000214. Review.

PMID:
26126196
43.

Arterial hypertension in children with hemolytic uremic syndrome after kidney transplantation.

Hoenecke J, Hartmann H, Melk A.

Pediatr Transplant. 2015 Aug;19(5):504-9. doi: 10.1111/petr.12533. Epub 2015 Jun 13.

PMID:
26073101
44.

Aortic Pulse Wave Velocity in Healthy Children and Adolescents: Reference Values for the Vicorder Device and Modifying Factors.

Thurn D, Doyon A, Sözeri B, Bayazit AK, Canpolat N, Duzova A, Querfeld U, Schmidt BM, Schaefer F, Wühl E, Melk A; 4C Study Consortium.

Am J Hypertens. 2015 Dec;28(12):1480-8. doi: 10.1093/ajh/hpv048. Epub 2015 May 5.

PMID:
25944878
45.

Zinc-α2-Glycoprotein Exerts Antifibrotic Effects in Kidney and Heart.

Sörensen-Zender I, Bhayana S, Susnik N, Rolli V, Batkai S, Baisantry A, Bahram S, Sen P, Teng B, Lindner R, Schiffer M, Thum T, Melk A, Haller H, Schmitt R.

J Am Soc Nephrol. 2015 Nov;26(11):2659-68. doi: 10.1681/ASN.2014050485. Epub 2015 Mar 18.

46.

Senescence-Induced Oxidative Stress Causes Endothelial Dysfunction.

Bhayadia R, Schmidt BM, Melk A, Hömme M.

J Gerontol A Biol Sci Med Sci. 2016 Feb;71(2):161-9. doi: 10.1093/gerona/glv008. Epub 2015 Mar 3.

PMID:
25735595
47.

Markers of bone metabolism are affected by renal function and growth hormone therapy in children with chronic kidney disease.

Doyon A, Fischer DC, Bayazit AK, Canpolat N, Duzova A, Sözeri B, Bacchetta J, Balat A, Büscher A, Candan C, Cakar N, Donmez O, Dusek J, Heckel M, Klaus G, Mir S, Özcelik G, Sever L, Shroff R, Vidal E, Wühl E, Gondan M, Melk A, Querfeld U, Haffner D, Schaefer F; 4C Study Consortium.

PLoS One. 2015 Feb 6;10(2):e0113482. doi: 10.1371/journal.pone.0113482. eCollection 2015.

48.

Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort.

Trautmann A, Bodria M, Ozaltin F, Gheisari A, Melk A, Azocar M, Anarat A, Caliskan S, Emma F, Gellermann J, Oh J, Baskin E, Ksiazek J, Remuzzi G, Erdogan O, Akman S, Dusek J, Davitaia T, Özkaya O, Papachristou F, Firszt-Adamczyk A, Urasinski T, Testa S, Krmar RT, Hyla-Klekot L, Pasini A, Özcakar ZB, Sallay P, Cakar N, Galanti M, Terzic J, Aoun B, Caldas Afonso A, Szymanik-Grzelak H, Lipska BS, Schnaidt S, Schaefer F; PodoNet Consortium.

Clin J Am Soc Nephrol. 2015 Apr 7;10(4):592-600. doi: 10.2215/CJN.06260614. Epub 2015 Jan 29.

49.

Improvement of biological age by physical activity.

Melk A, Tegtbur U, Hilfiker-Kleiner D, Eberhard J, Saretzki G, Eulert C, Kerling A, Nelius AK, Hömme M, Strunk D, Berliner D, Röntgen P, Kück M, Bauersachs J, Hilfiker A, Haverich A, Bara C, Stiesch M.

Int J Cardiol. 2014 Oct 20;176(3):1187-9. doi: 10.1016/j.ijcard.2014.07.236. Epub 2014 Aug 12. No abstract available.

PMID:
25223816
50.

Vascular importance of the miR-212/132 cluster.

Kumarswamy R, Volkmann I, Beermann J, Napp LC, Jabs O, Bhayadia R, Melk A, Ucar A, Chowdhury K, Lorenzen JM, Gupta SK, Batkai S, Thum T.

Eur Heart J. 2014 Dec 1;35(45):3224-31. doi: 10.1093/eurheartj/ehu344. Epub 2014 Sep 12.

PMID:
25217442

Supplemental Content

Support Center